Pillstats
Rx only · Ointment, Augmented · Topical

Betamethasone Dipropionate

Betamethasone Dipropionate

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1514
US makers6 labelers
Packages13
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.218$0.436$0.655$0.873Dec 2025Apr 2026Jul 2026
$0.659
Latest avg · Jul 22, 2026
-13%
Since Dec 17, 2025
6
Active US suppliers
38%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.0K5.9K8.9K12K2025 Q12025 Q22025 Q32025 Q42026 Q1
9.2K
Rx · 2026 Q1
449K
Units dispensed
+2%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown3SUPPLYING
Actavis Pharma, Inc.unknown2SUPPLYING
Burel Pharmaceuticals, LLCunknown2SUPPLYING
E. Fougera & Co. a division of Fougera Pharmaceuticals, LLCunknown2SUPPLYING
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.